Remote Endarterectomy Devices Market

Remote Endarterectomy Devices Market Size and Share Forecast Outlook 2025 to 2035

The Remote Endarterectomy Devices Market is estimated to be valued at USD 263.7 million in 2025 and is projected to reach USD 429.5 million by 2035, registering a compound annual growth rate (CAGR) of 5.0% over the forecast period.

Quick Stats for Remote Endarterectomy Devices Market

• Remote Endarterectomy Devices Market Value (2025): USD 263.7 million
• Remote Endarterectomy Devices Market Forecast Value (2035): USD 429.5 million
• Remote Endarterectomy Devices Market Forecast CAGR: 5.0%
• Leading Segment in Remote Endarterectomy Devices Market in 2025: Aortic (38.5%)
• Key Growth Regions in Remote Endarterectomy Devices Market: North America, Asia-Pacific, Europe
• Top Key Players in Remote Endarterectomy Devices Market: Scanlan International, 3M Company, Accuray Incorporated, Alliqua BioMedical, Delcath Systems, ICU Medical, iRhythm Technologies

Remote Endarterectomy Devices Market Key Takeaways

Metric	Value
Remote Endarterectomy Devices Market Estimated Value in (2025 E)	USD 263.7 million
Remote Endarterectomy Devices Market Forecast Value in (2035 F)	USD 429.5 million
Forecast CAGR (2025 to 2035)	5.0%

Why is the Remote Endarterectomy Devices Market Growing?

The Remote Endarterectomy Devices market is witnessing steady growth, driven by the increasing prevalence of vascular diseases and the demand for minimally invasive surgical interventions. Rising incidences of atherosclerosis, arterial occlusions, and peripheral artery diseases have created a critical need for advanced endarterectomy devices that offer precise plaque removal while minimizing complications. Adoption is being supported by technological advancements in device design, including enhanced navigation, imaging integration, and improved catheter systems that allow surgeons to perform procedures remotely with higher accuracy.

The market is further strengthened by growing awareness among healthcare providers regarding patient safety, reduced recovery times, and improved surgical outcomes associated with remote procedures. Hospitals and specialized clinics are increasingly implementing these devices to optimize operating room efficiency and enhance procedural success rates.

Continuous research collaborations, clinical trials, and regulatory approvals are facilitating the development of safer and more effective devices As vascular disease prevalence continues to rise and minimally invasive interventions gain prominence, the Remote Endarterectomy Devices market is expected to maintain sustainable growth, supported by innovation, clinical adoption, and increased healthcare infrastructure investments.

Segmental Analysis

The remote endarterectomy devices market is segmented by product, application, end user, and geographic regions. By product, remote endarterectomy devices market is divided into Aortic, Carotid, General Surgery, and Lower Extremity. In terms of application, remote endarterectomy devices market is classified into Long Segment Occlusions, Stent Removal, and Failed Fem-Pop Bypass.

Based on end user, remote endarterectomy devices market is segmented into Hospitals, Specialized Clinics, Medical Device Manufacturers, and Research Centers And Laboratory. Regionally, the remote endarterectomy devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Aortic Product Segment

The aortic product segment is projected to hold 38.5% of the market revenue in 2025, positioning it as the leading product type. Growth in this segment is being driven by the high incidence of aortic occlusions and aneurysms requiring precise plaque removal and vessel restoration. Remote endarterectomy devices designed for aortic applications enable surgeons to perform complex procedures with enhanced accuracy, reducing the risk of vessel damage and post-operative complications.

Advanced imaging guidance, flexible catheter systems, and software-assisted navigation contribute to improved procedural outcomes and patient safety. Hospitals and surgical centers are increasingly adopting these products due to their ability to optimize operating room efficiency and reduce recovery times.

The ability to perform minimally invasive procedures while maintaining high success rates has strengthened preference for aortic devices As healthcare providers continue to prioritize patient safety, efficiency, and advanced surgical capabilities, the aortic product segment is expected to maintain market leadership, supported by ongoing technological innovation and growing demand for vascular interventions.

Insights into the Long Segment Occlusions Application Segment

The long segment occlusions application segment is anticipated to account for 45.7% of the market revenue in 2025, making it the leading application area. Growth is being driven by the increasing prevalence of extended arterial blockages that require precise and controlled removal for effective treatment. Remote endarterectomy devices offer enhanced reach and maneuverability, allowing surgeons to treat longer occluded vessels with minimal invasiveness.

Integration with imaging technologies and navigational software ensures accurate plaque removal while reducing procedure times and patient recovery periods. The adoption of these devices is supported by hospitals and vascular surgery centers seeking safer alternatives to traditional open surgeries. Clinical outcomes are improved due to reduced intraoperative risks, lower complication rates, and shorter hospital stays.

Regulatory approvals, continuous product innovation, and growing awareness of minimally invasive treatment benefits are further supporting segment growth As demand for effective long segment occlusion treatments rises globally, this application segment is expected to remain the primary driver of market expansion.

Insights into the Hospitals End-User Segment

The hospitals end-user segment is projected to hold 42.3% of the market revenue in 2025, establishing it as the leading end-use category. Growth in this segment is being driven by the increasing adoption of remote endarterectomy devices for minimally invasive vascular procedures that improve patient safety, operational efficiency, and surgical outcomes. Hospitals are investing in advanced surgical technologies, imaging systems, and staff training to enhance procedural precision and reduce complications.

The ability to perform complex endarterectomy procedures remotely allows for optimized utilization of operating room resources and shorter patient recovery times. Increasing vascular disease prevalence and rising patient demand for minimally invasive interventions are further fueling adoption.

Integration with hospital information systems, compliance with regulatory standards, and the emphasis on outcome-based care reinforce the preference for hospitals as primary end users As healthcare institutions continue to prioritize efficiency, patient safety, and high-quality surgical outcomes, the hospitals segment is expected to maintain market leadership, supported by continuous innovation, clinical adoption, and increasing procedural volumes.

Market Overview

Remote Endarterectomy Devices Market Overview

Remote Endarterectomy (RE) is minimally invasive procedure which is a combination of surgical and endovascular techniques. Remote Endarterectomy (RE) is performed through a small inguinal incision. Although it is implemented through a small inguinal incision, it allows the complete debulking of the arterial plaque.

Remote Endarterectomy is basically used for the treatment of long-segmented superficial femoral artery (SFA) occlusive disease. This procedure is more preferred over other processes for the reason that, it is also used to treat iliac artery occlusive disease and stent removal.

RE is a better and long-lasting alternative for the standard bypass procedures. Remote Endarterectomy Device are the devices which are mainly used to remove the severe atherosclerotic blockages from the major arteries of the leg in an invasive procedure requiring a single incision in the research.

The current Remote Endarterectomy Device on the market has limited applications due to its design. Remote Endarterectomy is used in the peripheral vascular surgery to eliminate plaque from an occluded femoral artery. Use and maintain the native artery.

Products which are presently used by the surgeons have restricted flexibility with a fixed diameter metal ring that cannot accommodate changes in the size of the artery and irregular, calcified plaque formation.

Analysis of Remote Endarterectomy Devices Market By Key Countries

Country	CAGR
China	6.8%
India	6.3%
Germany	5.8%
Brazil	5.3%
USA	4.8%
UK	4.3%
Japan	3.8%

Country-wise Analysis

The Remote Endarterectomy Devices Market is expected to register a CAGR of 5.0% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 6.8%, followed by India at 6.3%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates.

Japan posts the lowest CAGR at 3.8%, yet still underscores a broadly positive trajectory for the global Remote Endarterectomy Devices Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 5.8%.

The USA Remote Endarterectomy Devices Market is estimated to be valued at USD 92.0 million in 2025 and is anticipated to reach a valuation of USD 92.0 million by 2035. Sales are projected to rise at a CAGR of 0.0% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 14.2 million and USD 6.7 million respectively in 2025.

Key Players in the Remote Endarterectomy Devices Market

• Scanlan International
• 3M Company
• Accuray Incorporated
• Alliqua BioMedical
• Delcath Systems
• ICU Medical
• iRhythm Technologies

Scope of the Report

Item	Value
Quantitative Units	USD 263.7 Million
Product	Aortic, Carotid, General Surgery, and Lower Extremity
Application	Long Segment Occlusions, Stent Removal, and Failed Fem-Pop Bypass
End User	Hospitals, Specialized Clinics, Medical Device Manufacturers, and Research Centers And Laboratory
Regions Covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Covered	United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa
Key Companies Profiled	Scanlan International, 3M Company, Accuray Incorporated, Alliqua BioMedical, Delcath Systems, ICU Medical, and iRhythm Technologies

Remote Endarterectomy Devices Market by Segments

Product:

• Aortic
• Carotid
• General Surgery
• Lower Extremity

Application:

• Long Segment Occlusions
• Stent Removal
• Failed Fem-Pop Bypass

End User:

• Hospitals
• Specialized Clinics
• Medical Device Manufacturers
• Research Centers And Laboratory

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa